Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Imaging Studies III: Computed Tomography

Imaging Studies III: Computed Tomography

DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Diagnostic and therapeutic challenges in claudin 18.2-positive gastric cancer treated with zolbetuximab: Intrapatient heterogeneity or secondary loss of expression?

Journal of cancer research and clinical oncology·2026

Same author

Staging accuracy of MRI of the prostate with special reference to the influence of the time of last ejaculation on the detection of seminal vesicle invasion.

Clinical radiology·2023

Same author

[SARS-CoV-2-associated deaths in adult persons up to 50 years of age].

Rechtsmedizin (Berlin, Germany)·2021

Same author

Prostatic Artery Embolization: Influence of Cone-Beam Computed Tomography on Radiation Exposure, Procedure Time, and Contrast Media Use.

Cardiovascular and interventional radiology·2021

Same author

Image quality and safety of automated carbon dioxide digital subtraction angiography in femoropopliteal lesions: Results from a randomized single-center study.

European journal of radiology·2021

Same author

Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial.

Radiation oncology (London, England)·2020

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

[Dynamic contrast-enhanced MRI of the prostate: comparison of two different post-processing algorithms].

D Beyersdorff¹, L Lüdemann, E Dietz

¹Department of Radiology, Charité, Universitätsmedizin Berlin, Campus Mitte. dirk.beyersdorff@charite.de

Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin

|March 29, 2011

Summary

A commercial software tool and a custom algorithm showed similar effectiveness in detecting prostate cancer using dynamic contrast-enhanced MRI. Both methods provide reliable analysis for identifying prostate cancer, aiding in diagnosis.

More Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model

Published on: April 18, 2015

Related Experiment Videos

Last Updated: Jun 3, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model

Published on: April 18, 2015

Area of Science:

Radiology
Oncology
Medical Imaging Analysis

Background:

Prostate cancer detection relies heavily on advanced imaging techniques.
Dynamic contrast-enhanced MRI (DCE-MRI) offers valuable insights into prostate tissue perfusion.
Accurate post-processing of DCE-MRI data is crucial for reliable cancer detection.

Purpose of the Study:

To assess the efficacy of a commercial post-processing software for prostate cancer detection via DCE-MRI.
To compare its performance against a custom-developed algorithm in clinical settings.

Main Methods:

Forty-eight patients with confirmed prostate cancer underwent standard and DCE-MRI before prostatectomy.
Data were analyzed using both a commercial tool (Dyna CAD for Prostate) and a custom algorithm.
Histopathology served as the gold standard for comparison.

Main Results:

Sensitivity for prostate cancer detection was 78% for the custom algorithm and 60% for the commercial tool.
Specificities were 79% and 82%, respectively.
No statistically significant difference (p=0.06) was found between the two algorithms' detection capabilities.

Conclusions:

The commercial software and custom algorithm demonstrated comparable performance in detecting prostate cancer.
The commercial tool provides a reliable and efficient method for analyzing DCE-MRI in prostate cancer diagnosis.